Brief: Pmv Pharmaceuticals Provides A Progress Update On Pynnacle Clinical Trial

Pmv Pharmaceuticals

23/10/2024 14:38

Oct 23 (Reuters) - PMV Pharmaceuticals Inc  PMVP.O :
    * PMV PHARMACEUTICALS PROVIDES A PROGRESS UPDATE ON PYNNACLE
CLINICAL TRIAL
    * PMV PHARMACEUTICALS INC - COLLABORATES WITH MDACC AND MSK
FOR
PHASE 1B STUDY IN AML/MDS
    * PMV PHARMACEUTICALS INC - TO PROVIDE INTERIM DATA BY
MID-2025,
NDA SUBMISSION BY END OF 2026
    * PMV PHARMACEUTICALS INC - ENROLLMENT ON TRACK IN PHASE 2
PYNNACLE TRIAL, INTERIM ANALYSIS BY MID-2025
    * PMV PHARMACEUTICALS INC - DISCONTINUES ENROLLMENT IN PHASE
1B
COMBINATION ARM OF PYNNACLE TRIAL

Source text for Eikon:  ID:nGNX56dtn6 
Further company coverage:  PMVP.O 

 ((Reuters.Briefs@thomsonreuters.com))